The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review

Journal of Psychosomatic Research

Volumn 71, Issue 4, 2011, Pages 223-231

  Magyar Russell, Gina ^a,b   Thombs, Brett D ^c   Cai, Jennifer X ^b   Baveja, Tarun ^d   Kuhl, Emily A ^e   Singh, Preet Paul ^f   Montenegro Braga Barroso, Marcela ^g   Arthurs, Erin ^b   Roseman, Michelle ^b   Amin, Nivee ^c   Marine, Joseph E ^c   Ziegelstein, Roy C ^c  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^f University of Alabama at Birmingham   (United States)

^g FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Anxiety; Depression; Implantable cardioverter defibrillator; Prevalence; Systematic review

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; DEFIBRILLATOR; DEPRESSION; HUMAN; PREVALENCE; PRIMARY PREVENTION; QUESTIONNAIRE; SECONDARY PREVENTION; SELF REPORT; STRUCTURED INTERVIEW; SYMPTOM; SYSTEMATIC REVIEW;

ADULT; ANXIETY; ANXIETY DISORDERS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; PREVALENCE; QUALITY OF LIFE;

EID: 80052682735     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2011.02.014     Document Type: Article

References (73)

1. U.S. Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute Implantable cardioverter defibrillator: How does it work? Available at:, Accessed January/17, 2011. http://www.nhlbi.nih.gov/health/dci/Diseases/icd/icd_howdoes.html.
2. DeFrances C.J., Lucas C.A., Buie V.C., Golosinskiy A. 2006 National hospital discharge survey. Natl Health Stat Rep 2008, 5:1-20.
3. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1933-1940.
4. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
5. Hammill S.C., Kremers M.S., Kadish A.H., Stevenson L.W., Heidenreich P.A., Lindsay B.D., et al. Review of the ICD registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 2009, 6:1397-1401.
6. Sears S.F., Todaro J.F., Lewis T.S., Sotile W., Conti J.B. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999, 22:481-489.
7. Burke J., Hallas C., Clark-Carter D., White D., Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br J Health Psychol 2003, 8:165-178.
8. Sola C.L., Bostwick J.M. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 2005, 80:232-237.
9. Bostwick J.M., Sola C.L. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am 2007, 30:677-688.
10. Kamphuis H.C., De Leeuw J.R., Derksen R., Hauer R., Winnubst J.A. A 12-month quality of life assessment of cardiac arrest survivors treated with or without an implantable cardioverter defibrillator. Europace 2002, 4:417-425.
11. Sears S.F., Lewis T.S., Kuhl E.A., Conti J.B. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005, 46:451-457.
12. Luderitz B., Jung W., Deister A., Marneros A., Manz M. The quality of life after the implantation of a cardioverter/defibrillator in malignant arrhythmias. Dtsch Med Wochenschr 1993, 118:285-289.
13. Sears S.F., Burns J.L., Handberg E., Sotile W.M., Conti J.B. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2001, 24:1113-1117.
14. Berlin J.A. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 1997, 350:185-186.
15. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, D.C. 4th ed.
16. World Health Organization International statistical classification of diseases and related health problems, 10th revision, version for 2007 Available at:, Accessed 10/3, 2010. http://apps.who.int/classifications/apps/icd/icd10online/.
17. Spitzer R.L., Endicott J., Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978, 35:773-782.
18. Agresti A., Coull B.A. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 1998, 52:119-126.
19. Hedges L.V. Estimation of effect size from a series of independent experiments. Psychol Bull 1982, 92:490-499.
20. Fitchet A., Doherty P.J., Bundy C., Bell W., Fitzpatrick A.P., Garratt C.J. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart 2003, 89:155-160.
21. Crow S.J., Collins J., Justic M., Goetz R., Adler S. Psychopathology following cardioverter defibrillator implantation. Psychosomatics 1998, 39:305-310.
22. Godemann F., Butter C., Lampe F., Linden M., Schlegl M., Schultheiss H.P., et al. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004, 27:321-326.
23. Jacq F., Foulldrin G., Savoure A., Anselme F., Baguelin-Pinaud A., Cribier A., et al. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. Gen Hosp Psychiatry 2009, 31:266-273.
24. Johansen J.B., Pedersen S.S., Spindler H., Andersen K., Nielsen J.C., Mortensen P.T. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients. Europace 2008, 10:545-551.
25. Kapa S., Rotondi-Trevisan D., Mariano Z., Aves T., Irvine J., Dorian P., et al. Psychopathology in patients with ICDs over time: results of a prospective study. Pacing Clin Electrophysiol 2010, 33:198-208.
26. Kamphuis H.C.M., de Leeuw J.R.J., Derksen R., Hauer R.N.W., Winnubst J.A.M. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 2003, 10:381-389.
27. Lemon J., Edelman S. Psychological adaptation to ICDs and the influence of anxiety sensitivity. Psychol Health Med 2007, 12:163-171.
28. Pedersen S.S., Van Den Berg M., Erdman R.A., Van Son J., Jordaens L., Theuns D.A. Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality. Pacing Clin Electrophysiol 2009, 32:184-192.
29. Fritzsche K., Forster F., Schweickhardt A., Kanwischer H., Drinkmann A., Rabung S., et al. Depressive coping is a predictor for emotional distress and poor quality of life in a German-Austrian sample of cardioverter-defibrillator implant recipients at 3months and 1year after implantation. Gen Hosp Psychiatry 2007, 29:526-536.
30. Thomas S.A., Friedmann E., Gottlieb S.S., Liu F., Morton P.G., Chapa D.W., et al. Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung 2009, 38:109-120.
31. Molenberghs G., Thijs H., Jansen I., Beunckens C., Kenward M.G., Mallinckrodt C., et al. Analyzing incomplete longitudinal clinical trial data. Biostatistics 2004, 5:445-464.
32. Whang W., Albert C.M., Sears S., Lampert R., Conti J.B., Wang P.J., et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) Study. J Am Coll Cardiol 2005, 45:1090-1095.
33. Bilge A.K., Ozben B., Demircan S., Cinar M., Yilmaz E., Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006, 29:619-626.
34. Undavia M., Goldstein N.E., Cohen P., Sinthawanarong K., Singson M., Bhutani D., et al. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life. Pacing Clin Electrophysiol 2008, 31:1411-1418.
35. Van den Broek K.C., Nyklicek I., Van der Voort P.H., Alings M., Denollet J. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol 2008, 31:850-857.
36. Francis J.L., Weinstein A.A., Krantz D.S., Haigney M.C., Stein P.K., Stone P.H., et al. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosom Med 2009, 71:821-827.
37. Chevalier P., Verrier P., Kirkorian G., Touboul P., Cottraux J. Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator. Psychother Psychosom 1996, 65:49-56.
38. Duru F., Buchi S., Klaghofer R., Mattmann H., Sensky T., Buddeberg C., et al. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life?. Heart 2001, 85:375-379.
39. Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006, 21:30-38.
40. Pedersen S.S., Sears S.F., Burg M.M., Van Den Broek K.C. Does ICD indication affect quality of life and levels of distress?. Pacing Clin Electrophysiol 2009, 32:153-156.
41. Dunbar S.B., Jenkins L.S., Hawthorne M., Kimble L.P., Dudley W.N., Slemmons M., et al. Factors associated with outcomes 3months after implantable cardioverter defibrillator insertion. Heart Lung 1999, 28:303-315.
42. Almeida L., Kashdan T.B., Nunes T., Coelho R., Albino-Teixeira A., Soares-da-Silva P. Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. Eur J Clin Pharmacol 2008, 64:575-582.
43. Kunz R., Vist G., Oxman A.D. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2007, 2:MR000012.
44. Smith G., Dunbar S.B., Valderrama A.L., Viswanathan B. Gender differences in implantable cardioverter-defibrillator patients at the time of insertion. Prog Cardiovasc Nurs 2006, 21:76-82.
45. Mitchell J.E., Hellkamp A.S., Mark D.B., Anderson J., Poole J.E., Lee K.L., et al. Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2008, 155:501-506.
46. Sears S.F., Sowell L.D., Kuhl E.A., Kovacs A.H., Serber E.R., Handberg E., et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol 2007, 30:858-864.
47. Schron E.B., Exner D.V., Yao Q., Jenkins L.S., Steinberg J.S., Cook J.R., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002, 105:589-594.
48. Sears S.F., Conti J.B., Curtis A.B., Saia T.L., Foote R., Wen F. Affective distress and implantable cardioverter defibrillators: cases for psychological and behavioral interventions. Pacing Clin Electrophysiol 1999, 22:1831-1834.
49. Dougherty C.M., Lewis F.M., Thompson E.A., Baer J.D., Kim W. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004, 27:1594-1602.
50. Lewin R.J., Coulton S., Frizelle D.J., Kaye G., Cox H. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart 2009, 95:63-69.
51. Frizelle D.J., Lewin R.J.P., Kaye G., Hargreaves C., Hasney K., Beaumont N., et al. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol 2004, 9:381-392.
52. Crossmann A., Schulz S.M., Kuhlkamp V., Ritter O., Neuser H., Schumacher B., et al. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med 2010, 72:434-441.
53. Burg M.M., Lampert R., Joska T., Batsford W., Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med 2004, 66:898-902.
54. Dougherty C.M., Glenny R., Kudenchuk P.J. Aerobic exercise improves fitness and heart rate variability after an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev 2008, 28:307-311.
55. Dunbar S.B., Langberg J.J., Reilly C.M., Viswanathan B., McCarty F., Culler S.D., et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009, 3210:1259-1271.
56. Edelman S., Lemon J., Kirkness A. Educational intervention for patients with automatic implantable cardioverter defibrillators. Aust J Adv Nurs 2007, 24:26-32.
57. van den Broek K.C., Nyklicek I., van der Voort P.H., Alings M., Meijer A., Denollet J. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J Am Coll Cardiol 2009, 54:531-537.
58. Smeulders E.S., van Haastregt J.C., Dijkman-Domanska B.K., van Hoef E.F., van Eijk J.T., Kempen G.I. Nurse- and peer-led self-management programme for patients with an implantable cardioverter defibrillator; a feasibility study. BMC Nurs 2007, 6:6.
59. Baumert J., Schmitt C., Ladwig K.H. Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges. Psychosom Med 2006, 68:591-597.
60. Friedmann E., Thomas S.A., Inguito P., Kao C.W., Metcalf M., Kelley F.J., et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol 2006, 17:65-72.
61. Frizelle D.J., Lewin B., Kaye G., Moniz-Cook E.D. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: the ICDC. Br J Health Psychol 2006, 11:293-301.
62. Hegel M.T., Griegel L.E., Black C., Goulden L., Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter defibrillators: a longitudinal investigation. Int J Psychiatry Med 1997, 27:57-69.
63. Herrmann C., von zur Muhen F., Schaumann A., Buss U., Kemper S., Wantzen C., et al. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997, 20:95-103.
64. Kim J.S., Pressler S.J., Welch J.L., Damush T., Sloan R.S., Wu J., et al. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs 2009, 24:398-409.
65. Lache B., Meyer T., Herrmann-Lingen C. Social support predicts hemodynamic recovery from mental stress in patients with implanted defibrillators. J Psychosom Res 2007, 63:515-523.
66. Ladwig K., Deisenhofer I., Simon H., Schmitt C., Baumert J.J. Characteristics associated with low treatment satisfaction in patients with implanted cardioverter defibrillators: results from the LICAD study. Pacing Clin Electrophysiol 2005, 28:506-513.
67. Leosdottir M., Sigurdsson E., Reimarsdottir G., Gottskalksson G., Torfason B., Vigfusdottir M., et al. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 2006, 8:168-174.
68. Luyster F.S., Hughes J.W., Waechter D., Josephson R. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom Med 2006, 68:794-800.
69. Luyster F.S., Hughes J.W., Gunstad J. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator. J Cardiovasc Nurs 2009, 24:10-17.
70. Newall E.G., Lever N.A., Prasad S., Hornabrook C., Larsen P.D. Psychological implications of ICD implantation in a New Zealand population. Europace 2007, 9:20-24.
71. Pedersen S.S., van Domburg R.T., Theuns D.A., Jordaens L., Erdman R.A. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005, 149:664-669.
72. Sowell L.V., Sears S.F., Walker R.L., Kuhl E.A., Conti J.B. Anxiety and marital adjustment in patients with implantable cardioverter defibrillator and their spouses. J Cardiopulm Rehabil Prev 2007, 27:46-49.
73. Wallace R.L., Sears S.F., Lewis T.S., Griffis J.T., Curtis A., Conti J.B. Predictors of quality of life in long-term recipients of implantable cardioverter defibrillators. J Cardiopulm Rehabil 2002, 22:278-281.